ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Sinovac applies for conditional approval of COVID-19 vaccine in China

Tens of thousands have already gotten CoronaVac; Sinopharm shot also under review

Sinovac Biotech says tests show its CoronaVac shot provides protective efficacy and meets the standards of the World Health Organization and China's State Food and Drug Administration.   © AP

China's medicine regulator is reviewing a second domestically developed COVID-19 vaccine for conditional approval.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more